Sophie Nadaud Selected Research

Sophie Nadaud Research Topics

Disease

4	Fibrosis (Cirrhosis) 01/2023 - 11/2004
4	Vascular Remodeling 01/2023 - 03/2016
4	Pulmonary Arterial Hypertension 04/2022 - 04/2015
4	Heart Failure 01/2022 - 01/2019
3	Hypoxia (Hypoxemia) 03/2016 - 11/2003
3	Inflammation (Inflammations) 04/2015 - 06/2007
2	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2023 - 10/2016
2	Hypertrophy 01/2022 - 01/2019
2	Pulmonary Hypertension 01/2022 - 01/2018
2	Hypertension (High Blood Pressure) 10/2009 - 08/2004
1	Neoplasms (Cancer) 01/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Infarction (Infarctions) 01/2020
1	Ischemia 01/2020
1	Myocardial Infarction 01/2020
1	Infections 01/2018
1	Pain (Aches) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Congenital Heart Defects (Congenital Heart Defect) 10/2016
1	Familial Primary Pulmonary Hypertension 10/2016
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2013
1	Vascular Diseases (Vascular Disease) 12/2012
1	Neointima 11/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2011
1	Disease Progression 07/2011
1	Edema (Dropsy) 11/2004

Drug/Important Bio-Agent (IBA)

3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2009 - 08/2004
2	Platelet-Derived Growth FactorIBA 04/2022 - 01/2022
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2012
2	CytokinesIBA 01/2022 - 01/2012
2	ChemokinesIBA 01/2022 - 01/2012
2	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 10/2016 - 01/2013
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2009 - 08/2004
1	Prokaryotic Initiation Factor-2IBA 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	IntegrinsIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	CalciumIBA 01/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	treprostinil FDA Link 01/2018
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2018
1	GalactosidasesIBA 03/2016
1	LeptinIBA 04/2015
1	hydralazine 4-anisaldehyde hydrazoneIBA 01/2013
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2012
1	Peptides (Polypeptides)IBA 12/2012
1	ApelinIBA 12/2012
1	lysophosphatidic acidIBA 11/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 07/2011
1	Immunoglobulin M (IgM)IBA 07/2011
1	arginine methyl esterIBA 10/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2009
1	Atorvastatin (Lipitor)FDA Link 10/2009
1	Vasoconstrictor AgentsIBA 06/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2004
1	EndotoxinsIBA 11/2004
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2004
1	DNA (Deoxyribonucleic Acid)IBA 08/2004
1	Messenger RNA (mRNA)IBA 11/2003
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2003
1	ElementsIBA 11/2003

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2015
1	Lung Transplantation 01/2023
1	Ligation 07/2011